Dr. Herbert Lepor discusses prostate cancer in an interview at NYU Medical Center. This program is part of FORA.tv's NYU Medical Center Wellness Series.
Dr. Lepor discusses who is most at risk, possible lifestyle factors of developing prostate cancer, current treatments and side effects, as well as the future of prostate research and treatment.
Herbert Lepor, M.D. is Professor and Chairman of the Department of Urology for NYU School of Medicine and Professor of Pharmacology at NYU School of Medicine. He is also Urologist in Chief at Tisch Hospital.
Dr. Herbert Lepor received his undergraduate degree from the University of California Los Angeles in 1975 and his doctor of medicine from The Johns Hopkins University School of Medicine in 1979. Dr. Lepor completed his surgery and urology residency training at The Johns Hopkins Hospital.
Since 1986, Dr. Lepor’s academic appointments have been in the Departments of Urology at The Johns Hopkins University School of Medicine, Washington University School of Medicine, and the Medical College of Wisconsin. In 1995, Dr. Lepor was awarded the Gold Cystoscope Award by The American Urological Association.
In 1993, Dr. Lepor was appointed Professor and Chairman of the Department of Urology, NYU School of Medicine and Professor of Pharmacology at NYU School of Medicine. He is presently Urologist in Chief at Tisch Hospital. Dr. Lepor received the title “Martin Spatz Chairman of the Department of Urology” when he became the recipient of an endowed chair in 1997. Dr. Lepor’s primary clinical and basic research interests are related to the prostate. His clinical practice is currently limited exclusively to surgical management of prostate cancer.
Dr. Lepor has served on the editorial boards for four major urological journals and has authored over 191 peer reviewed articles, 50 book chapters, and 12 books related to prostate cancer, benign prostatic hyperplasia, and the pharmacology of the prostate. He is the co-founder and editor of Reviews in Urology. Dr. Lepor has been a visiting professor at over 25 institutions. Some of Dr. Lepor’s landmark scientific contributions have focused on the identification of the autonomic intervention regulating male sexual function, development of the nerve sparing radical prostatectomy, improving outcomes following radical retropubic prostatectomy, characterization of the prostate alpha1 adrenoceptor, and the medical and surgical management of benign prostatic hyperplasia.
Dr. Lepor is a member of the American Association of Genitourinary Surgeons, Clinical Society of the American Association of Genitourinary Surgeons, the American Surgical Association, and the Johns Hopkins University Society of Scholars.